Colgate-Palmolive (NYSE:CL) Stock Holdings Boosted by AlphaCore Capital LLC

AlphaCore Capital LLC boosted its holdings in Colgate-Palmolive (NYSE:CL) by 21.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,454 shares of the company’s stock after acquiring an additional 800 shares during the quarter. AlphaCore Capital LLC’s holdings in Colgate-Palmolive were worth $462,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of CL. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive during the 2nd quarter valued at $25,000. Continuum Advisory LLC increased its holdings in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive during the third quarter valued at $53,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $64,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

CL opened at $94.37 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock has a market capitalization of $77.10 billion, a P/E ratio of 27.04, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company’s 50 day simple moving average is $98.32 and its 200-day simple moving average is $98.50. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.12%. Colgate-Palmolive’s payout ratio is 57.31%.

Analyst Ratings Changes

Several research firms have recently issued reports on CL. Morgan Stanley upped their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Thursday, November 14th. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, Sanford C. Bernstein increased their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a report on Tuesday, July 30th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $105.11.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.